Background: Laparoscopic splenectomy (LS) is becoming the gold standard in
the treatment of several splenic diseases. Shorter postoperative stay and m
ore rapid return to full activity are the primary advantages of LS.
Methods: Prospective data collection of 44 consecutive LS (group 1) and com
parison with a historical control group of 56 consecutive open splenectomie
s (OS) (group 2) were performed for hematologic diseases.
Results: The LS patients started earlier on an oral diet (p < 0.0001) and l
eft the hospital sooner (p < 0.0002) than OS patients. Less blood transfusi
on (p < 0.004) and pain medication (p < 0.0001) was required by LS patients
. They also had fewer postoperative complications (p < 0.03). Compared by d
iagnosis, patients with laparoscopic idiopathic thrombocytopenic purpura or
Hodgkin's disease started to eat earlier (p < 0.0001) and left the hospita
l sooner (p < 0.01), Multivariate analysis showed that time to oral diet an
d postoperative stay was related to operative technique and age. Morbidity
and pain medications were related, respectively, to transfusion requirement
s and type of surgical approach.
Conclusions: Used to manage hematologic diseases, LS is feasible, effective
, and safe. It offers several advantages over the open approach. The type o
f surgical approach seems to be the crucial factor in determining the lengt
h of the postoperative course.